Multifocal breast cancer documented in large‐format histology sections
Open Access
- 27 December 2012
- Vol. 119 (6) , 1132-1139
Abstract
BACKGROUND: The prognostic significance of molecular phenotype in breast cancer is well established in the literature. Recent studies have demonstrated that subgross lesion distribution (unifocal, multifocal, and diffuse) and disease extent also carry prognostic significance in this disease. However, the correlation of molecular phenotypes with subgross parameters has not yet been investigated in detail. METHODS: In total, 444 consecutive invasive breast cancers that were documented in large‐format histology slides and worked up with detailed radiologic‐pathologic correlation were sampled into tissue microarray blocks and stained immunohistochemically to delineate the molecular subtypes. RESULTS: Diffuse or multifocal distribution of the invasive component of breast carcinomas in this series was associated with a 4.14‐fold respectively 2.75‐fold risk of cancer‐related death compared with unifocal tumors irrespective of molecular phenotype. Patients who had human epidermal growth factor receptor 2 (HER2)‐positive cancers; estrogen receptor‐negative, progesterone receptor‐negative, and HER2‐negative (triple‐negative) cancers; or basal‐like cancers had a 2.18‐fold, 2.33‐fold, and 4.07‐fold risk of dying of disease, respectively, compared with patients who had luminal A carcinomas. Unifocal luminal A, HER2‐positive, and basal‐like cancers were associated with significantly better long‐term survival outcomes than their multifocal or diffuse counterparts; luminal B and triple‐negative tumors also had the same tendency. In multivariate analysis, patient age, tumor size category, lymph node status, lesion distribution, and molecular phenotypes remained significant. CONCLUSIONS: Multifocality and diffuse distribution of the invasive component were associated with significantly poorer survival in women with breast carcinomas compared with unifocal disease in patients with luminal A, HER2 type, and basal‐like cancers. Molecular classification of breast cancer is a powerful tool but gains in power when combined with conventional and subgross morphologic parameters. Cancer 2013. © 2013 American Cancer Society.Keywords
This publication has 39 references indexed in Scilit:
- Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancerBreast Cancer Research and Treatment, 2011
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort studyBreast Cancer Research and Treatment, 2010
- Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?Breast Cancer Research and Treatment, 2010
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research, 2008
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991